DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Coles AJ, Fox E, Vladic A et al.
Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes.
Lancet Neurol 2011;
10: 338-348
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.